BioCentury
ARTICLE | Company News

Noven's Estradot approved in Europe

March 22, 2001 8:00 AM UTC

NOVN received European marketing approval for its Estradot transdermal 17-beta estradiol to treat menopausal symptoms and to prevent post-menopausal osteoporosis. NOVN and partner Novartis (NVS; SWX:N...